EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between time-to-antibiotics and clinical outcomes in neutropenic fever after hematopoietic stem cell transplant

Samuel L Windham, Christopher A Guidry, Anthony D Sung, Marin H Kollef, Steven Q Simpson

Supportive Care in Cancer · 2026-11 · 34 (11)

DOI: 10.1007/s00520-026-11141-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 28.10.2026. Verfasst von Samuel L Windham und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS, USA. Swindham2@kumc.edu. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Anti-Bacterial Agents, Fever, Time-to-Treatment. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guidelines recommend empiric antibiotics within one hour for neutropenic fever, extrapolated primarily from sepsis literature. Whether modest variation in time-to-antibiotics (TTA) affects outcomes in antibiotic-naïve hematopoietic stem cell transplant (HSCT) recipients remains unclear.

Methods

We conducted a retrospective cohort study of neutropenic fever episodes occurring within 30 days of HSCT at a single academic center (2018–2022). We included antibiotic-naïve episodes (no intravenous antibiotics in the 24 h preceding fever) with timestamp-validated TTA. Primary outcome was clinical deterioration (new vasopressor requirement ≥ 6 h, mechanical ventilation, or 90-day mortality). Secondary analyses examined bacteremia and blood culture yield.

Results

Among 224 antibiotic-naïve episodes, 17 (7.6%) experienced clinical deterioration. Median TTA was 1.2 h (IQR 0.8–2.2), with 86 (38.4%) receiving antibiotics within one hour. In the primary categorical analysis, TTA was not associated with deterioration (≤ 1 h vs > 1 h, adjusted OR 1.18, 95% CI 0.37–3.78, P = .78); a per-hour continuous parameterization was similarly null (adjusted OR 1.03, 95% CI 0.85–1.24, P = .80). Recognized pathogen bacteremia occurred in 59 episodes (26.3%) and was not associated with 90-day mortality (adjusted OR 1.98, 95% CI 0.50–7.90, P = .33); a sensitivity analysis using any-positive cultures (69/224 [30.8%]) yielded similar findings (OR 1.15, 95% CI 0.31–4.28, P = .84). Of 11 deaths, 10 (91%) occurred without preceding acute deterioration. Pre-antibiotic and post-antibiotic cultures had similar recognized pathogen positivity (27.1% vs 23.5%; adjusted OR 1.03, 95% CI 0.28–3.85, P = .97).

Conclusion

In antibiotic-naïve adult HSCT recipients with neutropenic fever, TTA was not associated with deterioration and bacteremia was not associated with mortality. Per-hour TTA effects were bounded below the minimum detectable effect size, challenging the extrapolation of the 1-h antibiotic rule from septic shock cohorts to this population. Multicenter validation is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationAnti-Bacterial AgentsFeverTime-to-TreatmentNeutropeniaHumansRetrospective StudiesFemaleMaleMiddle AgedAdultBacteremiaTime FactorsTreatment Delay

Stichwörter der Autor:innen

BacteremiaHematopoietic stem cell transplantNeutropenic feverTime-to-antibiotics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS, USA. Swindham2@kumc.edu.
  • Acute Care Surgery Division, University of Kansas Medical Center, Kansas City, KS, USA.
  • Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.
  • Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Windham, S. L., Guidry, C. A., Sung, A. D., Kollef, M. H., & Simpson, S. Q. (2026). Association between time-to-antibiotics and clinical outcomes in neutropenic fever after hematopoietic stem cell transplant. Supportive Care in Cancer, 34(11). https://doi.org/10.1007/s00520-026-11141-8

Vancouver

Windham SL, Guidry CA, Sung AD, Kollef MH, Simpson SQ. Association between time-to-antibiotics and clinical outcomes in neutropenic fever after hematopoietic stem cell transplant. Supportive Care in Cancer. 2026;34(11). doi:10.1007/s00520-026-11141-8

BibTeX
@article{Windham2026,
  author = {Windham, Samuel L and Guidry, Christopher A and Sung, Anthony D and Kollef, Marin H and Simpson, Steven Q},
  title = {Association between time-to-antibiotics and clinical outcomes in neutropenic fever after hematopoietic stem cell transplant},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {11},
  doi = {10.1007/s00520-026-11141-8}
}
Kostenlos starten →